SERINC3-NCOA5 Fusion FISH Probe
The SERINC3-NCOA5 Fusion FISH Probe is used to confirm a fusion of the SERINC3 and NCOA5 genes. The fusion of the SERINC3 and NCOA5 genes has been associated with Uterine Carcinosarcoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SERINC3-NCOA5-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SERINC3-NCOA5-20-AQAQ | 20 (40 μL) | 200 μL |
|
SERINC3 Gene Summary
The Serine Incorporator 3 (SERINC3) gene is located on chr20 :43124863-43150726 at 20q13.12.
Gene Name: Serine Incorporator 3
Chromosome: CHR20: 43124863 -43150726
Locus: 20q13.12
NCOA5 Gene Summary
This gene encodes a coregulator for the alpha and beta estrogen receptors and the orphan nuclear receptor NR1D2. The protein localizes to the nucleus, and is thought to have both coactivator and corepressor functions. Its interaction with nuclear receptors is independent of the AF2 domain on the receptors, which is known to regulate interaction with other coreceptors. Several alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2017]
Gene Name: Nuclear Receptor Coactivator 5
Chromosome: CHR20: 44689625 -44718580
Locus: 20q13.12
Gene Diseases
The SERINC3 NCOA5 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Carcinosarcoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|